跳至主要内容
临床试验/ISRCTN04305346
ISRCTN04305346已完成未知

Comparative study of efficacy and safety of Structum® and Chondrosulf® in patients with symptomatic osteoarthritis of the knee: a multicentre, randomised, double-blind, double placebo-controlled, parallel group study

Pierre Fabre Research Institute (Institut de Recherche Pierre Fabre) (France)0 个研究点目标入组 837 人开始时间: 2011年4月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
837

研究概览

简要总结

2013 results in https://pubmed.ncbi.nlm.nih.gov/23493263/ (added 18/12/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • •Patients aged from 50 to 80 years with symptomatic femorotibial knee OA fulfilling American College of Rheumatology (ACR) criteria for knee OA, with a Kellgren-Lawrence radiological grade II or III, a global pain score greater than or equal to 40 on a 100mm Visual Analogue Scale (VAS) and a Lequesne Index greater than or equal to 7

排除标准

  • •1. Isolated symptomatic femoropatellar osteoarthritis of the knee
  • •2. Symptomatic hip OA homolateral to the target knee
  • •3. Inflammatory, infectious or metabolic arthritis
  • •4. Bisphosphonates or strontium ranelate in the 3 months preceding inclusion
  • •5. Corticosteroid treatment during the month preceding inclusion
  • •6. Intra-articular steroid injection in the 2 months preceding inclusion
  • •7. Intra-articular hyaluronic acid in the 6 months preceding inclusion
  • •8. Non steroidal anti-inflammatory drugs (NSAIDs) in the 2 days preceding inclusion
  • •9. Articular lavage of target knee in the 3 months preceding inclusion

研究者

发起方
Pierre Fabre Research Institute (Institut de Recherche Pierre Fabre) (France)

相似试验